Literature DB >> 27541265

Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition.

Jinqiang Hou1, Carlie L Charron2, Milan M Fowkes2, Leonard G Luyt3.   

Abstract

The ghrelin receptor, also referred to as the growth hormone secretagogue receptor 1a (GHS-R1a), is a G protein-coupled receptor (GPCR) primarily expressed in the brain and pituitary. The wide spectrum of biological functions of GHS-R1a has rendered it a target for therapeutic drugs and for molecular imaging agents, for a variety of diseases. An improved understanding of the binding mechanism of a ligand to GHS-R1a would provide guidance on ligand design. This study investigates the binding of G-7039, a peptidomimetic agonist, to the GHS-R1a. A series of computational studies including homology modeling, molecular docking, molecular dynamics (MD) simulations, and binding free energy calculations were carried out in conjunction with amino acid replacements on G-7039. The results suggest that the first three residues on the N-terminal segment of the peptidomimetic are bound to three hydrophobic sub-pockets in the receptor binding site, with the driving force for binding mainly from hydrophobic interactions. It has been reported that a charge-charge interaction between the positively charged terminal amine of the agonist and Glu124 on the receptor serves as an anchor point for binding. However, our studies suggest that this interaction is not strong enough to anchor a ligand to the ghrelin receptor in the absence of hydrophobic interactions. The resulting computational model provides insight into structure activity relationship analysis for the ghrelin receptor and will assist in future ligand design.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  G-7039; GPCR; Ghrelin receptor; Molecular dynamics simulation; Molecular modeling; Peptidomimetic

Mesh:

Substances:

Year:  2016        PMID: 27541265     DOI: 10.1016/j.ejmech.2016.07.078

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Development of a [68Ga]-ghrelin analogue for PET imaging of the ghrelin receptor (GHS-R1a).

Authors:  C L Charron; M S McFarland; S Dhanvantari; L G Luyt
Journal:  Medchemcomm       Date:  2018-09-17       Impact factor: 3.597

Review 2.  Ghrelin Signaling: GOAT and GHS-R1a Take a LEAP in Complexity.

Authors:  Alfonso Abizaid; James L Hougland
Journal:  Trends Endocrinol Metab       Date:  2019-10-19       Impact factor: 12.015

3.  Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging.

Authors:  Rareş-Petru Moldovan; Sylvia Els-Heindl; Dennis J Worm; Torsten Kniess; Michael Kluge; Annette G Beck-Sickinger; Winnie Deuther-Conrad; Ute Krügel; Peter Brust
Journal:  Int J Mol Sci       Date:  2017-04-05       Impact factor: 5.923

4.  Development and Characterization of an 18F-labeled Ghrelin Peptidomimetic for Imaging the Cardiac Growth Hormone Secretagogue Receptor.

Authors:  Ahmed Abbas; Lihai Yu; Tyler Lalonde; Derek Wu; Jonathan D Thiessen; Leonard G Luyt; Savita Dhanvantari
Journal:  Mol Imaging       Date:  2018 Jan-Dec       Impact factor: 4.488

Review 5.  Ghrelin-Mediated Regeneration and Plasticity After Nervous System Injury.

Authors:  Irina Stoyanova; David Lutz
Journal:  Front Cell Dev Biol       Date:  2021-03-25

Review 6.  Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor.

Authors:  Gianfabio Giorgioni; Fabio Del Bello; Wilma Quaglia; Luca Botticelli; Carlo Cifani; E Micioni Di Bonaventura; M V Micioni Di Bonaventura; Alessandro Piergentili
Journal:  J Med Chem       Date:  2022-02-14       Impact factor: 7.446

Review 7.  A Decade's Progress in the Development of Molecular Imaging Agents Targeting the Growth Hormone Secretagogue Receptor.

Authors:  Marina D Childs; Leonard G Luyt
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.